Common questions about Savella (FAQ)
Q: What happens if a dose of Savella is missed?
If a dose is missed, regulatory documents advise skipping the missed dose entirely. The patient should then resume the regular dosing schedule at the next scheduled time. It is advised not to take a double dose at one time to try and make up for a dose that was forgotten.
Q: Can Savella be taken with over-the-counter pain medications like ibuprofen?
Regulatory documents caution about a potentially increased risk of bleeding when Savella is used together with certain nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen. Official information advises patients to be aware of this potential interaction.
Q: Does alcohol use affect the safety or effectiveness of Savella?
Official documentation advises caution regarding the use of alcoholic beverages while taking Savella. The medicine is specifically advised against for use in patients with substantial alcohol use or chronic liver disease, due to the risk of potential liver damage.
Q: How should Savella be stored?
The official product information specifies that Savella should be stored in its closed container at room temperature. It must be kept away from excessive heat, moisture, and direct light, and protected from freezing.
Q: Can Savella be crushed or split to take?
Savella is manufactured as an immediate-release, film-coated tablet. The official product information does not include instructions regarding crushing, splitting, or physically altering the tablets.
Q: What are the symptoms of an overdose of Savella?
Symptoms reported in regulatory contexts following acute overdose include confusion, extreme sleepiness, dizziness, and vomiting. Changes in heart rate and blood pressure, such as a fast heart rate and high blood pressure, were also reported.
Q: Is Savella an antidepressant or a pain reliever?
In the United States, Savella is officially approved only for the management of fibromyalgia, which is a chronic pain condition. It is chemically categorized as a selective serotonin and norepinephrine reuptake inhibitor (SNRI), a drug class that includes some medicines used to treat depression.
Q: Why is Savella prescribed for fibromyalgia and not other conditions?
In the U.S., Savella has received regulatory approval specifically for the management of fibromyalgia. It received regulatory approval based on clinical trial evidence supporting its use for this condition.
Q: How quickly do people typically notice a change after starting Savella?
Clinical trial evidence has not established a specific timeframe for patients to notice the full effect of the medicine. Official documentation indicates that, like similar treatments, it may take several weeks for the effects to become fully evident.
Q: Does Savella help with fatigue associated with fibromyalgia?
Clinical studies supporting the drug’s approval focused on key symptoms such as pain and changes in physical function. While fatigue is a symptom often associated with fibromyalgia, the drug’s approved indication relates to the overall management of the condition.
Q: What is the main difference between Savella and Cymbalta?
Both Savella (milnacipran) and Cymbalta (duloxetine) are classified as selective serotonin and norepinephrine reuptake inhibitors (SNRIs). However, their specific approved uses differ in the U.S. Savella is only approved for fibromyalgia, while Cymbalta has approval for fibromyalgia alongside other conditions.
Q: Can Savella cause weight gain or weight loss?
In clinical trials, changes in body weight were reported as adverse reactions. Official product information notes that decreased weight was a common occurrence, while increased weight was reported less frequently among patients.
Q: Is it common to feel worse when first starting Savella?
Many of the most common side effects, such as nausea, headache, and constipation, tend to be reported more often when treatment is first started. Official information describes a gradual dose increase procedure intended to help manage how the patient tolerates the initial phase of treatment.
Q: Can Savella affect sleep patterns?
Yes, official regulatory information reports that difficulty falling or staying asleep (insomnia) is one of the common side effects that was observed in clinical trials.
Q: Are there specific foods or drinks to avoid while taking Savella?
Savella may be taken with or without food according to official labeling. Beyond advising caution regarding substantial alcohol use, regulatory sources do not list specific dietary restrictions that must be followed.
Q: What if Savella doesn't seem to be working after a few weeks?
The drug is intended for the long-term management of fibromyalgia. The evidence for the approved use is based on clinical trials spanning several months, which suggests that the full effect of the medication may take time to become apparent.
Q: Is Savella known to cause sexual side effects?
Yes, sexual dysfunction was reported as an adverse reaction in clinical trials. This can include decreased libido (sex drive) and issues with ejaculation in male patients.
Q: Does Savella affect blood pressure or heart rate?
Official labeling states that the medication can lead to sustained increases in both heart rate and blood pressure, and these factors should be monitored during the course of treatment. Cases of significant blood pressure elevation have been reported.
Q: Is Savella considered a controlled substance?
No, according to regulatory classification in the U.S., Savella (milnacipran) is not designated as a controlled substance under the Controlled Substances Act.
Q: What is the risk of dependence or withdrawal with Savella?
Regulatory documents state that withdrawal symptoms have been reported following the sudden discontinuation of treatment. A gradual reduction in dosage is officially recommended when stopping the medicine to help minimize potential discontinuation symptoms.
Q: Can Savella be taken during pregnancy?
Regulatory information indicates that, based on data from animal studies, there is a potential for the drug to cause harm to the developing fetus. The official label advises that the medication should be used during pregnancy only if the potential benefit to the patient is believed to justify the potential risk to the fetus.
Q: Is Savella safe for older adults to use?
Official studies observed no overall differences in efficacy or safety between older and younger adults in clinical trials. However, the official label notes that greater sensitivity of some older individuals to the effects of the drug cannot be completely ruled out.
Q: Are there common reasons why a doctor might stop prescribing Savella?
Official information indicates that the medication may be discontinued due to specific safety concerns. These can include a sustained increase in heart rate or blood pressure, or the emergence of signs of liver damage (hepatotoxicity).
Q: Do studies support the long-term use of Savella?
The drug's approved indication for the management of fibromyalgia is based on clinical trials, including those of an extended duration, which support its use as a treatment intended for long-term administration.
Q: Does Savella cause 'brain fog' or difficulty concentrating?
Difficulty concentrating is reported in regulatory contexts. This symptom may occur in the context of hyponatremia (low sodium levels), which is an adverse reaction that can potentially develop during treatment.
Q: What is the chemical name for Savella?
The active ingredient in Savella is milnacipran hydrochloride. The official chemical name is (±)-cis-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide hydrochloride.
Q: Can Savella be used by people with kidney problems?
Official prescribing information indicates that the use of Savella is generally not recommended for patients who have end-stage kidney disease. For people with moderate or severe kidney impairment, a lower total daily dose is described in the official product information.
Q: Is there a generic version of Savella available?
The active ingredient in Savella is milnacipran. Generic versions of milnacipran hydrochloride tablets have received approval from the FDA for use in the U.S.
Q: How does Savella compare to Lyrica for fibromyalgia?
Savella (milnacipran) and Lyrica (pregabalin) are both approved by the FDA for the management of fibromyalgia. However, they belong to different classes of medication: Savella is an SNRI, and Lyrica is an anticonvulsant and GABA analog. They act on the body through different mechanisms.
Q: What is the typical age range of people prescribed Savella?
The medication is officially approved for use in adult patients, meaning those 18 years of age and older. The clinical trials supporting its use focused on the adult population, including older adults with fibromyalgia.
Q: Does Savella interact with supplements like St. John's Wort?
Official warnings state that Savella should not be taken concurrently with other agents that increase serotonin levels, which includes herbal supplements such as St. John's Wort. Taking them together may increase the risk of a serious condition called Serotonin Syndrome.
Q: Is it normal to have increased sweating while on Savella?
Yes, based on clinical trial data, increased sweating (hyperhidrosis) is reported as a very common side effect associated with taking this medication.
Q: Can people with a history of depression take Savella?
The drug carries a warning regarding the potential risk of suicidal thoughts and behaviors, particularly in young adults. Because depression itself is associated with an increased risk of suicide, patients taking Savella who have a history of depression require careful monitoring according to official guidance.
Q: Can Savella affect liver function tests?
Official information indicates that the drug has been associated with mild elevations of certain liver enzymes (ALT and AST) in clinical trials. In rare cases, more severe liver damage, known as fulminant hepatitis, has been reported.
Q: Is Savella a monotherapy or is it usually combined with other treatments?
Savella is approved for the management of fibromyalgia. Official documents do not mandate that it be used as a monotherapy. In clinical practice, the management of fibromyalgia often involves a comprehensive approach that includes both drug and non-drug therapies.
Q: Can Savella cause confusion or dizziness?
Yes, dizziness is reported as a common side effect in clinical trials. Confusion has also been reported as a potential symptom of hyponatremia (low sodium levels), which is an adverse reaction that may occur during treatment.
Q: Is Savella effective for men and women equally?
Clinical trials for the approved use of Savella included both male and female patients, and the drug is approved for the adult population as a whole. The official prescribing information does not generally provide separate, detailed data on efficacy broken down specifically by sex.
Q: What is the difference between an SNRI like Savella and an SSRI?
Savella is classified as a Selective Serotonin and Norepinephrine Reuptake Inhibitor (SNRI). It is believed to work by increasing the levels of both chemical messengers, serotonin and norepinephrine, in the central nervous system. Selective Serotonin Reuptake Inhibitors (SSRIs) primarily work by increasing the levels of only serotonin.
Q: Does Savella work immediately or does it need time to build up in the system?
While the drug is rapidly absorbed into the body, the therapeutic action that results in the clinical effect for fibromyalgia may take time. The official dose instructions involve a gradual increase over several days, suggesting the full effect is not immediate.
Q: Are there any warnings about driving or operating machinery while taking Savella?
The official Patient Medication Guide cautions that this medication may cause drowsiness or affect an individual's judgment, thinking, and movements. Official guidance cautions against driving or operating hazardous machinery until patients are aware of how the medication affects them.
Q: What is the half-life of Savella in the body?
The mean elimination half-life of the active ingredient, milnacipran, in the body is approximately 8 hours. This measure describes the time it takes for half of the drug to be eliminated from the bloodstream.
Q: Does Savella cause insomnia or vivid dreams?
Difficulty sleeping (insomnia) is reported as a common side effect in the official product information. While insomnia is common, vivid dreams are not explicitly listed in the very common or common side effect categories.
Q: Can Savella make anxiety worse?
The official Patient Medication Guide advises that new or worsening symptoms of anxiety and panic attacks should be monitored, especially when a patient first starts the medication or when the dosage is increased.
Q: What is the main function of norepinephrine reuptake inhibition in Savella?
Savella is an SNRI that prevents the reabsorption (reuptake) of norepinephrine, which is a chemical messenger in the central nervous system. This action is thought to contribute to the drug's overall mechanism and its effect in managing fibromyalgia.
Q: Are there specific patient groups that should use caution with Savella?
Official warnings and precautions exist for several patient groups. These include people with a history of seizures, uncontrolled narrow-angle glaucoma, pre-existing high blood pressure or certain heart conditions, and those with a history of substantial alcohol use.
